阻塞性睡眠呼吸暂停及持续气道正压通气在重度肥胖男性功能性性腺功能减退中的作用
本研究纳入204例无已知性腺功能减退的复杂重度肥胖男性住院患者,横断面分析显示失代偿性OSAS与总睾酮降低独立相关;对14例新诊断患者进行3个月CPAP治疗的前后对照,总睾酮升高且与ODI改善相关,独立于BMI。
要点
- 重度肥胖男性中失代偿性OSAS与低总睾酮独立相关。
- CPAP治疗3个月可提高总睾酮,且独立于BMI变化。
- ODI改善与CPAP后睾酮升高相关,提示OSAS可逆成分。
核心结论
- 失代偿性OSAS与重度肥胖男性的低睾酮相关,CPAP治疗可独立于BMI变化改善总睾酮。
研究设计与样本
- 横断面研究连续纳入204例无已知性腺功能减退的复杂重度肥胖男性住院患者,进行多导睡眠监测或CPAP期间夜间血氧监测及血液检测。
- 另对14例新诊断OSAS患者进行纵向研究,评估CPAP治疗3个月前后总睾酮变化。
主要发现
- 204例中127例总睾酮≤10.4 nmol/L。
- BMI、2型糖尿病、C反应蛋白和失代偿性OSAS与总睾酮独立相关(P值分别为.039、.006、.003和.014)。
- CPAP治疗3个月后总睾酮升高(P=.009),ODI与这一改善相关且独立于BMI(P=.04)。
关键数值与推荐
- 失代偿性OSAS定义为新诊断患者呼吸暂停低通气指数(AHI)或治疗患者氧减饱和度指数(ODI)>30次/小时。
- 低总睾酮定义为总睾酮≤10.4 nmol/L。
临床怎么用
- 对重度肥胖男性应评估OSAS,失代偿性OSAS是低睾酮的相关因素。
- CPAP治疗可能改善总睾酮,且不依赖BMI变化。
局限性
- 纵向CPAP研究样本量仅14例。
- 横断面设计无法确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Only a few studies have reported a correlation between severe obstructive sleep apnea syndrome (OSAS) and hypogonadism in patients with obesity, regardless of body mass index (BMI). However, longitudinal studies exploring the role of continuous positive airway pressure (CPAP) on gonadal function are scanty. OBJECTIVE: This work aimed to investigate in men with severe/complicated obesity the role of OSAS in decreasing testosterone levels and evaluate the effects of CPAP on hormonal status. METHODS: This cross-sectional study consecutively enrolled 204 male inpatients with complicated severe obesity, without known hypogonadism. Polysomnography (or overnight oximetry during CPAP) and blood tests for inflammation and metabolic and hormonal profiles were performed. "Decompensated OSAS" was defined as an Apnea/Hypopnea Index (AHI) in newly diagnosed, or Oxygen Desaturation Index (ODI) in treated patients, above 30 events/hour. A multiple linear regression was implemented to identify the independent factors correlated with total testosterone (TT). Lastly, a longitudinal study of 14 newly diagnosed patients was performed to evaluate the effects of CPAP on TT after 3 months of treatment. RESULTS: A total of 127 of 204 patients showed low TT (≤10.4 nmol/L). BMI, type 2 diabetes, C-reactive protein, and decompensated OSAS were independently associated with TT (P = .039; P = .006, P = .003, and P = .014, respectively). After 3 months of CPAP therapy, TT was higher (P = .009) and ODI was associated with such improvement, independently of BMI (P = .04). CONCLUSION: Decompensated OSAS was found to correlate with low testosterone in men with severe obesity. Moreover, CPAP therapy was shown to improve TT independently of BMI changes.
引用
- Amodeo A, Cangiano B, Del Duca N, et al. The Role of Obstructive Sleep Apnea and CPAP Therapy in the Functional Hypogonadism of Male Patients With Severe Obesity. J Clin Endocrinol Metab. 2026. PMID: 41284733. doi:10.1210/clinem/dgaf635
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。